Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Ebbehoj, A, Stochholm, K, Jacobsen, SF, Trolle, C, Jepsen, P, Robaczyk, MG, Rasmussen, ÅK, Feldt-Rasmussen, U, Thomsen, RW, Søndergaard, E & Poulsen, PL 2021, 'Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study', The Journal of clinical endocrinology and metabolism, bind 106, nr. 5, s. e2251-e2261. https://doi.org/10.1210/clinem/dgaa965

APA

Ebbehoj, A., Stochholm, K., Jacobsen, S. F., Trolle, C., Jepsen, P., Robaczyk, M. G., Rasmussen, Å. K., Feldt-Rasmussen, U., Thomsen, R. W., Søndergaard, E., & Poulsen, P. L. (2021). Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study. The Journal of clinical endocrinology and metabolism, 106(5), e2251-e2261. https://doi.org/10.1210/clinem/dgaa965

CBE

MLA

Vancouver

Author

Ebbehoj, Andreas ; Stochholm, Kirstine ; Jacobsen, Sarah Forslund ; Trolle, Christian ; Jepsen, Peter ; Robaczyk, Maciej Grzegorz ; Rasmussen, Åse Krogh ; Feldt-Rasmussen, Ulla ; Thomsen, Reimar Wernich ; Søndergaard, Esben ; Poulsen, Per Løgstrup. / Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma : A Population-based Study. I: The Journal of clinical endocrinology and metabolism. 2021 ; Bind 106, Nr. 5. s. e2251-e2261.

Bibtex

@article{df3870aef93a45f285ad54a045a498de,
title = "Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study",
abstract = "CONTEXT: Pheochromocytoma and sympathetic paraganglioma (PPGL) are rare catecholamine-secreting tumors but recent studies suggest increasing incidence. Traditionally, PPGL are described to present with paroxysmal symptoms and hypertension, but existing data on clinical presentation of PPGL come from referral centers.OBJECTIVE: We aimed to describe time trends in clinical presentation and incidence of PPGL in a population-based study.METHODS: We conducted a nationwide retrospective cohort study of a previously validated cohort of 567 patients diagnosed with PPGL in Denmark 1977-2015. We collected clinical data from medical records of a geographic subcohort of 192 patients. We calculated age-standardized incidence rates (SIRs) and prevalence for the nationwide cohort and descriptive statistics on presentation for the subset with clinical data.RESULTS: SIRs increased from 1.4 (95% CI 0.2-2.5) per million person-years in 1977 to 6.6 (95% CI 4.4-8.7) per million person-years in 2015, corresponding to a 4.8-fold increase. The increase was mainly due to incidentally found tumors that were less than 4 cm and diagnosed in patients older than 50 years with no or limited paroxysmal symptoms of catecholamine excess. On December 31, 2015, prevalence of PPGL was 64.4 (CI 95% 57.7-71.2) per million inhabitants. Of 192 patients with clinical data, 171 (89.1%) had unilateral pheochromocytoma, while unilateral paraganglioma (n = 13, 6.8%) and multifocal PPGL (n = 8, 4.2%) were rare.CONCLUSION: Incidence of PPGL has increased 4.8-fold from 1977 to 2015 due to a {"}new{"} group of older patients presenting with smaller incidentally found PPGL tumors and few or no paroxysmal symptoms.",
keywords = "clinical presentation, incidence, paraganglioma, pheochromocytoma, population based, prevalence",
author = "Andreas Ebbehoj and Kirstine Stochholm and Jacobsen, {Sarah Forslund} and Christian Trolle and Peter Jepsen and Robaczyk, {Maciej Grzegorz} and Rasmussen, {{\AA}se Krogh} and Ulla Feldt-Rasmussen and Thomsen, {Reimar Wernich} and Esben S{\o}ndergaard and Poulsen, {Per L{\o}gstrup}",
note = "{\textcopyright} The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.",
year = "2021",
month = may,
doi = "10.1210/clinem/dgaa965",
language = "English",
volume = "106",
pages = "e2251--e2261",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The/Endocrine Society",
number = "5",

}

RIS

TY - JOUR

T1 - Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma

T2 - A Population-based Study

AU - Ebbehoj, Andreas

AU - Stochholm, Kirstine

AU - Jacobsen, Sarah Forslund

AU - Trolle, Christian

AU - Jepsen, Peter

AU - Robaczyk, Maciej Grzegorz

AU - Rasmussen, Åse Krogh

AU - Feldt-Rasmussen, Ulla

AU - Thomsen, Reimar Wernich

AU - Søndergaard, Esben

AU - Poulsen, Per Løgstrup

N1 - © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PY - 2021/5

Y1 - 2021/5

N2 - CONTEXT: Pheochromocytoma and sympathetic paraganglioma (PPGL) are rare catecholamine-secreting tumors but recent studies suggest increasing incidence. Traditionally, PPGL are described to present with paroxysmal symptoms and hypertension, but existing data on clinical presentation of PPGL come from referral centers.OBJECTIVE: We aimed to describe time trends in clinical presentation and incidence of PPGL in a population-based study.METHODS: We conducted a nationwide retrospective cohort study of a previously validated cohort of 567 patients diagnosed with PPGL in Denmark 1977-2015. We collected clinical data from medical records of a geographic subcohort of 192 patients. We calculated age-standardized incidence rates (SIRs) and prevalence for the nationwide cohort and descriptive statistics on presentation for the subset with clinical data.RESULTS: SIRs increased from 1.4 (95% CI 0.2-2.5) per million person-years in 1977 to 6.6 (95% CI 4.4-8.7) per million person-years in 2015, corresponding to a 4.8-fold increase. The increase was mainly due to incidentally found tumors that were less than 4 cm and diagnosed in patients older than 50 years with no or limited paroxysmal symptoms of catecholamine excess. On December 31, 2015, prevalence of PPGL was 64.4 (CI 95% 57.7-71.2) per million inhabitants. Of 192 patients with clinical data, 171 (89.1%) had unilateral pheochromocytoma, while unilateral paraganglioma (n = 13, 6.8%) and multifocal PPGL (n = 8, 4.2%) were rare.CONCLUSION: Incidence of PPGL has increased 4.8-fold from 1977 to 2015 due to a "new" group of older patients presenting with smaller incidentally found PPGL tumors and few or no paroxysmal symptoms.

AB - CONTEXT: Pheochromocytoma and sympathetic paraganglioma (PPGL) are rare catecholamine-secreting tumors but recent studies suggest increasing incidence. Traditionally, PPGL are described to present with paroxysmal symptoms and hypertension, but existing data on clinical presentation of PPGL come from referral centers.OBJECTIVE: We aimed to describe time trends in clinical presentation and incidence of PPGL in a population-based study.METHODS: We conducted a nationwide retrospective cohort study of a previously validated cohort of 567 patients diagnosed with PPGL in Denmark 1977-2015. We collected clinical data from medical records of a geographic subcohort of 192 patients. We calculated age-standardized incidence rates (SIRs) and prevalence for the nationwide cohort and descriptive statistics on presentation for the subset with clinical data.RESULTS: SIRs increased from 1.4 (95% CI 0.2-2.5) per million person-years in 1977 to 6.6 (95% CI 4.4-8.7) per million person-years in 2015, corresponding to a 4.8-fold increase. The increase was mainly due to incidentally found tumors that were less than 4 cm and diagnosed in patients older than 50 years with no or limited paroxysmal symptoms of catecholamine excess. On December 31, 2015, prevalence of PPGL was 64.4 (CI 95% 57.7-71.2) per million inhabitants. Of 192 patients with clinical data, 171 (89.1%) had unilateral pheochromocytoma, while unilateral paraganglioma (n = 13, 6.8%) and multifocal PPGL (n = 8, 4.2%) were rare.CONCLUSION: Incidence of PPGL has increased 4.8-fold from 1977 to 2015 due to a "new" group of older patients presenting with smaller incidentally found PPGL tumors and few or no paroxysmal symptoms.

KW - clinical presentation

KW - incidence

KW - paraganglioma

KW - pheochromocytoma

KW - population based

KW - prevalence

UR - http://www.scopus.com/inward/record.url?scp=85103163412&partnerID=8YFLogxK

U2 - 10.1210/clinem/dgaa965

DO - 10.1210/clinem/dgaa965

M3 - Journal article

C2 - 33479747

VL - 106

SP - e2251-e2261

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -

ID: 65610353